Cargando…

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Cheila, Calado, Rita, Borrego, Pedro, Marcelino, José Maria, Bártolo, Inês, Rosado, Lino, Cavaco-Silva, Patrícia, Gomes, Perpétua, Família, Carlos, Quintas, Alexandre, Skar, Helena, Leitner, Thomas, Barroso, Helena, Taveira, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016255/
https://www.ncbi.nlm.nih.gov/pubmed/24156513
http://dx.doi.org/10.1186/1742-4690-10-110
_version_ 1782315477170651136
author Rocha, Cheila
Calado, Rita
Borrego, Pedro
Marcelino, José Maria
Bártolo, Inês
Rosado, Lino
Cavaco-Silva, Patrícia
Gomes, Perpétua
Família, Carlos
Quintas, Alexandre
Skar, Helena
Leitner, Thomas
Barroso, Helena
Taveira, Nuno
author_facet Rocha, Cheila
Calado, Rita
Borrego, Pedro
Marcelino, José Maria
Bártolo, Inês
Rosado, Lino
Cavaco-Silva, Patrícia
Gomes, Perpétua
Família, Carlos
Quintas, Alexandre
Skar, Helena
Leitner, Thomas
Barroso, Helena
Taveira, Nuno
author_sort Rocha, Cheila
collection PubMed
description BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth. RESULTS: CD4(+) T cells decreased from about 50% to below 30% in both children in the first five years of infection and the infecting R5 viruses were replaced by X4 viruses within the same period. With antiretroviral therapy, viral load in child 1 decreased to undetectable levels and CD4(+) T cells recovered to normal levels, which have been sustained at least until the age of 12. In contrast, viral load increased in child 2 and she progressed to AIDS and death at age 9. Beginning in the first year of life, child 1 raised high titers of antibodies that neutralized primary R5 isolates more effectively than X4 isolates, both autologous and heterologous. Child 2 raised a weak X4-specific Nab response that decreased sharply as disease progressed. Rate of evolution, nucleotide and amino acid diversity, and positive selection, were significantly higher in the envelope of child 1 compared to child 2. Rates of R5-to-X4 tropism switch, of V1 and V3 sequence diversification, and of convergence of V3 to a β-hairpin structure were related with rate of escape from the neutralizing antibodies. CONCLUSION: Our data suggests that the molecular and phenotypic evolution of the human immunodeficiency virus type 2 envelope are related with the dynamics of the neutralizing antibody response providing further support for a model in which Nabs play an important role in HIV-2 pathogenesis.
format Online
Article
Text
id pubmed-4016255
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40162552014-05-11 Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response Rocha, Cheila Calado, Rita Borrego, Pedro Marcelino, José Maria Bártolo, Inês Rosado, Lino Cavaco-Silva, Patrícia Gomes, Perpétua Família, Carlos Quintas, Alexandre Skar, Helena Leitner, Thomas Barroso, Helena Taveira, Nuno Retrovirology Research BACKGROUND: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4(+) T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are thought to play a central role in HIV-2 evolution and pathogenesis. However, the dynamic of the Nab response and resulting HIV-2 escape during acute infection and their impact in HIV-2 evolution and disease progression remain largely unknown. Our objective was to characterize the Nab response and the molecular and phenotypic evolution of HIV-2 in association with Nab escape in the first years of infection in two children infected at birth. RESULTS: CD4(+) T cells decreased from about 50% to below 30% in both children in the first five years of infection and the infecting R5 viruses were replaced by X4 viruses within the same period. With antiretroviral therapy, viral load in child 1 decreased to undetectable levels and CD4(+) T cells recovered to normal levels, which have been sustained at least until the age of 12. In contrast, viral load increased in child 2 and she progressed to AIDS and death at age 9. Beginning in the first year of life, child 1 raised high titers of antibodies that neutralized primary R5 isolates more effectively than X4 isolates, both autologous and heterologous. Child 2 raised a weak X4-specific Nab response that decreased sharply as disease progressed. Rate of evolution, nucleotide and amino acid diversity, and positive selection, were significantly higher in the envelope of child 1 compared to child 2. Rates of R5-to-X4 tropism switch, of V1 and V3 sequence diversification, and of convergence of V3 to a β-hairpin structure were related with rate of escape from the neutralizing antibodies. CONCLUSION: Our data suggests that the molecular and phenotypic evolution of the human immunodeficiency virus type 2 envelope are related with the dynamics of the neutralizing antibody response providing further support for a model in which Nabs play an important role in HIV-2 pathogenesis. BioMed Central 2013-10-24 /pmc/articles/PMC4016255/ /pubmed/24156513 http://dx.doi.org/10.1186/1742-4690-10-110 Text en Copyright © 2013 Rocha et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rocha, Cheila
Calado, Rita
Borrego, Pedro
Marcelino, José Maria
Bártolo, Inês
Rosado, Lino
Cavaco-Silva, Patrícia
Gomes, Perpétua
Família, Carlos
Quintas, Alexandre
Skar, Helena
Leitner, Thomas
Barroso, Helena
Taveira, Nuno
Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title_full Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title_fullStr Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title_full_unstemmed Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title_short Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
title_sort evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016255/
https://www.ncbi.nlm.nih.gov/pubmed/24156513
http://dx.doi.org/10.1186/1742-4690-10-110
work_keys_str_mv AT rochacheila evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT caladorita evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT borregopedro evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT marcelinojosemaria evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT bartoloines evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT rosadolino evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT cavacosilvapatricia evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT gomesperpetua evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT familiacarlos evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT quintasalexandre evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT skarhelena evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT leitnerthomas evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT barrosohelena evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse
AT taveiranuno evolutionofthehumanimmunodeficiencyvirustype2envelopeinthefirstyearsofinfectionisassociatedwiththedynamicsoftheneutralizingantibodyresponse